摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (E)-3-(4-chloro-2-fluorophenyl)acrylate

中文名称
——
中文别名
——
英文名称
methyl (E)-3-(4-chloro-2-fluorophenyl)acrylate
英文别名
methyl(2E)-3-(4-chloro-2-fluorophenyl)prop-2-enoate;methyl (E)-3-(4-chloro-2-fluorophenyl)prop-2-enoate
methyl (E)-3-(4-chloro-2-fluorophenyl)acrylate化学式
CAS
——
化学式
C10H8ClFO2
mdl
——
分子量
214.624
InChiKey
OCGRVPULGVALNH-HWKANZROSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    methyl (E)-3-(4-chloro-2-fluorophenyl)acrylatepotassium cyanide羟胺 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 18.0h, 以15%的产率得到(2E)-3-(4-chloro-2-fluorophenyl)-N-hydroxyprop-2-enamide
    参考文献:
    名称:
    Synthesis and structure–activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors
    摘要:
    Botulinum neurotoxins are the most toxic proteins currently known. Based on a recently identified potent lead structure, 2,4-dichlorocinnamic acid hydroxamate, herein we report on the structure- activity relationship of a series of hydroxamate BoNT/A inhibitors. Among them, 2-bromo-4-chlorocinnamic acid hydroxamate, 2-methyl-4-chlorocinnamic acid hydroxamate, and 2-trifluoromethyl-4-chlorocinnamic acid hydroxamate displayed comparable inhibitory activity to that of the lead structure. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.09.103
  • 作为产物:
    描述:
    膦酰基乙酸甲酯二乙酯4-氯-2-氟苯甲醛 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 18.5h, 以78%的产率得到methyl (E)-3-(4-chloro-2-fluorophenyl)acrylate
    参考文献:
    名称:
    Synthesis and structure–activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors
    摘要:
    Botulinum neurotoxins are the most toxic proteins currently known. Based on a recently identified potent lead structure, 2,4-dichlorocinnamic acid hydroxamate, herein we report on the structure- activity relationship of a series of hydroxamate BoNT/A inhibitors. Among them, 2-bromo-4-chlorocinnamic acid hydroxamate, 2-methyl-4-chlorocinnamic acid hydroxamate, and 2-trifluoromethyl-4-chlorocinnamic acid hydroxamate displayed comparable inhibitory activity to that of the lead structure. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.09.103
点击查看最新优质反应信息

文献信息

  • Iron-Catalyzed Carboamination of Olefins: Synthesis of Amines and Disubstituted β-Amino Acids
    作者:Bo Qian、Shaowei Chen、Ting Wang、Xinhao Zhang、Hongli Bao
    DOI:10.1021/jacs.7b06590
    日期:2017.9.20
    Intermolecular carboamination of olefins with general alkyl groups is an unsolved problem. Diastereoselective carboamination of acyclic olefins represents an additional challenge in intermolecular carboaminations. We have developed a general alkylamination of vinylarenes and the unprecedented diastereoselective anti-carboamination of unsaturated esters, generating amines and unnatural β-amino acids
    具有一般烷基的烯烃的分子间碳基化是一个未解决的问题。无环烯烃的非对映选择性碳胺化代表了分子间碳胺化的额外挑战。我们开发了乙烯基芳烃的一般烷基胺化和前所未有的不饱和酯的非对映选择性抗碳胺化,生成胺和非天然 β-氨基酸。这种烷基胺化是通过双官能烷基化试剂和催化剂实现的。很容易从脂肪酸合成的烷基二酰基过氧化物既可用作烷基化试剂,也可用作内部氧化剂。一项计算研究表明,将腈添加到碳正离子中是决定非对映选择性的步骤,并且提出了超共轭来解释高度非对映选择性的抗碳化。
  • Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators
    作者:Liangqin Guo、Zhixiong Ye、Feroze Ujjainwalla、Heather L. Sings、Iyassu K. Sebhat、John Huber、David H. Weinberg、Rui Tang、Tanya MacNeil、Constantin Tamvakopoulos、Qianping Peng、Euan MacIntyre、Lex H.T. van der Ploeg、Mark T. Goulet、Matthew J. Wyvratt、Ravi P. Nargund
    DOI:10.1016/j.bmcl.2008.04.049
    日期:2008.6
    Discovery of a series of tert-butyl pyrrolidine derived, potent and orally bioavailable melanocortin receptor subtype-4 (MC4R) selective modulators is disclosed. (C) 2008 Elsevier Ltd. All rights reserved.
  • CN115477606
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多